KLOW is not a therapeutic drug, not approved for human administration, and not intended for diagnostic purposes
Along this line of thought, it has been suggested that positively affecting the redox potential might benefit aspects neurologic functioning in the short term and may hold promise to contribute to attenuation of neurodegenerative processes that occur in MS over the longer term ( Glutathione is the principle naturally occurring antioxidant in neurons which protects against oxidative damage
Jul 2018
GLP-1 refers to the medication class known as glucagon-like peptide-1 receptor agonists a group of medications that regulate appetite, blood sugar, and metabolism
Your body burns roughly 20-30% of those calories when metabolizing protein [6][7] a clear win/win situation, wouldnt you think
Peptides are short chains of amino acids that act as signaling molecules, influencing processes like metabolism, tissue repair, and hormone regulation